The Bronchiolitis in Hospitalized Infants Study
A legfontosabb adatok
- Ki végzi
- IDeA States Pediatric Clinical Trials Network
- Hol
- Little Rock és Omaha (Egyesült Államok)Mind a 2 helyszín megnézése
- Azonosító
- Állapot
- Visszavonva
- Fázis
- Korai 1. fázis
- Kezdés
- 2023. okt. 9.
- Befejezés
- 2025. ápr. 14.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- Dexamethasone Oral
- A regiszteradat frissítve
- 2023. szeptember 14.
- Miért állt le
- The study was withdrawn with no participants enrolled due to the need for an IND from the FDA, which significantly expanded the scope of the study beyond what was originally anticipated for a pilot project within this network.
Ki vehet részt
- Életkor
- 0 hónap – 24 hónap
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Infants <24 months of age at time of enrollment
- Admitted to the hospitalist service with a diagnosis of bronchiolitis
- RSV and COVID-19 Negative
- At least one of the following clinical criteria:; personal history of breathing problems; personal history of eczema; parental history of asthma
- Parental ability to speak and read English or Spanish
Ki nem vehet részt
- Currently taking corticosteroids (inhaled or oral) or have taken corticosteroids within 7 days prior to hospitalization (per parental report and chart review)
- Known underlying heart failure, hypertension, gastrointestinal bleeding, liver disease, thyroid disease (per parental report and chart review)
- Preterm Infant (born at < 34 weeks' gestation)
- Diagnosis of asthma
- Admission to the intensive care unit (ICU) at time of enrollment
- Participants (caregivers) who, in the view of the investigator, whom are unlikely able to comply with the protocol requirements
Helyszínek itt: Egyesült Államok
- Arkansas Children's HospitalLittle Rock, Egyesült Államok
- University of Nebraska Medical CenterOmaha, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
The goal of this clinical trial is to determine whether it is possible to identify, enroll, and deliver the study intervention (the corticosteroid dexamethasone) in hospitalized infants with bronchiolitis.
A teljes eredeti leírásKevesebb
Participants in this study will be given two doses of dexamethasone within 72 hours of enrollment, followed by 30 days of safety monitoring.
Results of this feasibility pilot study may be used to inform the design of a future randomized controlled trial, whose results in turn could induce a paradigm shift in acute management of bronchiolitis.
A vizsgálat csoportja
- Dexamethasone AdministrationA vizsgált kezelés
Dexamethasone will be given orally to all consented participants. Two doses will be administered within 12-48 hours, with at least the 1st dose administered during the bronchiolitis hospitalization. If the participant is discharged before the 2nd dose, it will be administered at home.
Kezelés: Dexamethasone Oral
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- The Bronchiolitis in Hospitalized Infants (BroncHI) Study: A Feasibility Trial Aimed to Identify and Treat Hospitalized Infants With Bronchiolitis Most at Risk for Recurrent Wheezing and Asthma
- A regiszteradat frissítve
- 2023. szeptember 14.